Lipella Pharmaceuticals has renewed its collaboration with Cook MyoSite to support the clinical development of LP-310. The agreement focuses on manufacturing support for LP-310, a promising candidate undergoing clinical trials. The press release emphasizes forward-looking statements regarding strategy, financial position, regulatory approvals, and growth opportunities for the LP-310 pipeline. While the company expresses confidence in […]